Lyra Therapeutics (LYRA) Tax Provisions (2023 - 2025)
Quarterly Tax Provisions fell 66.67% to $2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Dec 2025, down 71.79% year-over-year, with the annual reading at $11000.0 for FY2025, 71.79% down from the prior year.
Lyra Therapeutics' Tax Provisions history spans 3 years, with the latest figure at $2000.0 for Q4 2025.
- Tax Provisions came in at $2000.0 for Q4 2025, down from $3000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $17000.0 in Q4 2023 to a low of $2000.0 in Q2 2025.
- The 3-year median for Tax Provisions is $9500.0 (2023), against an average of $9083.3.
- Year-over-year, Tax Provisions changed 0.0% in 2024 and then plummeted 83.33% in 2025.
- Lyra Therapeutics' Tax Provisions stood at $17000.0 in 2023, then crashed by 64.71% to $6000.0 in 2024, then plummeted by 66.67% to $2000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Tax Provisions are $2000.0 (Q4 2025), $3000.0 (Q3 2025), and $2000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 216,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Lyra Therapeutics | - | - | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 14,000.00 |